FDA-NCI Workshop on Therapeutic Cancer Vaccines

October 27, 2009

NEW LOCATION:
Masur Auditorium
Bldg. 10 -- NIH Campus

SAVE THE DATE!

OBJECTIVE AND SCOPE:
FDA and NCI are holding a public workshop intended to facilitate the development of safe and effective cancer vaccine by optimizing early phase clinical trials based on lessons learned from completed Phase III studies.

In this workshop, the role of randomized Phase II clinical trials and adaptive study designs will be discussed. Furthermore, the workshop will emphasize the importance of monitoring immune responses in early phase trials in order to optimize immunological therapies and incorporating pretreatment biomarkers in early phase clinical studies that could predict the effect of specific treatment for patients (predictive biomarkers) in order to identify a population likely to benefit.

ONLINE REGISTRATION (choose one)
Note: When registering, please indicate whether you need any special accommodations. Seating is limited and registration is on a first-come, first served basis. The workshop will also be available via live videocast and podcast through the NIH videocasting service. Updated information about the workshop and live videocasting will become available to registered participants.

PARTICIPATION IN-PERSON

PARTICIPATION VIA LIVE VIDEOCASTING & PODCASTING

Please visit the registration page to select which to attend.

ADDITIONAL INFORMATION

RECOMMENDED ACCOMMODATIONS

NIH VISITORS AND SECURITY

CAMPUS MAP AND PARKING

CONTACT

SPECIAL ACCOMMODATIONS

ORGANIZING COMMITTEE

Virginia Axline (NCI)
Ashok Batra, MD (FDA/CBER)
Peter Bross, MD (FDA/CBER)
Stephen Creekmore, PhD MD (NCI)
Syed Husain, PhD (FDA/CBER)
Bernadette Kawaley (FDA/CBER)
Ke Liu, MD, PhD (FDA/CDER)
Steven S. Oh, PhD (FDA/CBER)
Raj Puri, MD PhD (FDA/CBER)
Howard Streicher, MD (NCI)
Celia M. Witten, PhD MD (FDA/CBER)

PROGRAM COMMITTEE

Peter Bross, MD (FDA/CBER) - Co-chair
Stephen Creekmore, PhD MD (NCI)
Bernard Fox, PhD (Earle A. Chiles Research Institute) - iSBTc Representative
Thomas F. Gajewski, MD PhD (University of Chicago) - ASCO Representative
Joseph Gootenberg, MD (FDA/CDER)
Syed Husain, PhD (FDA/CBER) - Co-chair
Hyam Levitsky, MD (Johns Hopkins University) - AACR Representative
Ke Liu, MD, PhD (FDA/CDER)
Steven S. Oh, PhD (FDA/CBER) - Co-chair
Howard Streicher, MD (NCI)
Boguang Zhen, PhD (FDA/CBER)